Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review

Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH207713FSA
  • |
  • Pages: 44
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Respiri Ltd (RSH)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Respiri Ltd (Respiri), formerly iSonea Ltd, is a medical technology company that develops non-invasive medical devices and mobile health applications to improve the management of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The company's proprietary applications, software and devices will help people monitor the symptoms of their conditions and increase their awareness of risk of attack. Respiri's proprietary technology, Acoustic Respiratory Monitoring (ARM), helps capture, store and analyze respiratory sounds objectively and without relying on patient cooperation. The company's product portfolio includes PulmoTrack, SonoSentry, Wholter, and AirSonea. The company has operations in Australia, Israel and the US. Respiri is headquartered in Victoria, Australia.

Respiri Ltd Key Recent Developments

Jul 30,2018: Respiri: Quarterly report-appendix 4c for the period to 30 June 2018

Jun 14,2018: Respiri Announces the Appointment of New Chairman

Feb 26,2018: Respiri Reported its Half Year Ended 31 December 2017 results

Jan 29,2018: Respiri: Short CEO Update and Reaffirmation of 2018 Plans and Milestones

Dec 22,2017: Respiri Announces Appointment of Director & Board Remuneration

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Respiri Ltd-Key Facts 5

Respiri Ltd-Key Employees 6

Respiri Ltd-Key Employee Biographies 7

Respiri Ltd-Major Products and Services 8

Respiri Ltd-History 9

Respiri Ltd-Locations And Subsidiaries 11

Head Office 11

Other Locations & Subsidiaries 11

Section 2-Company Analysis 12

Company Overview 12

Respiri Ltd-Business Description 13

Respiri Ltd-SWOT Analysis 14

SWOT Analysis-Overview 14

Respiri Ltd-Strengths 14

Respiri Ltd-Weaknesses 15

Respiri Ltd-Opportunities 16

Respiri Ltd-Threats 17

Respiri Ltd-Key Competitors 18

Section 3-Company Financial Ratios 19

Financial Ratios-Capital Market Ratios 19

Financial Ratios-Annual Ratios 20

Performance Chart 22

Financial Performance 22

Financial Ratios-Interim Ratios 23

Financial Ratios-Ratio Charts 24

Section 4-Company's Lifesciences Financial Deals and Alliances 25

Respiri Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Respiri Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

Respiri Ltd, Recent Deals Summary 27

Section 5-Company's Recent Developments 28

Jul 30, 2018: Respiri: Quarterly report-appendix 4c for the period to 30 June 2018 28

Jun 14, 2018: Respiri Announces the Appointment of New Chairman 29

Feb 26, 2018: Respiri Reported its Half Year Ended 31 December 2017 results 30

Jan 29, 2018: Respiri: Short CEO Update and Reaffirmation of 2018 Plans and Milestones 31

Dec 22, 2017: Respiri Announces Appointment of Director & Board Remuneration 33

Oct 16, 2017: Respiri Appoints Former Senior Global Pfizer Executive Mario Gattino as Chief Executive Officer 34

Aug 29, 2017: Respiri Announced Its Annual Financial Report for the Year Ended 30 June 2017 35

May 17, 2017: Respiri: Appointment of New Company Secretary 37

Feb 28, 2017: Respiri's Text and App Messaging for Better Asthma Care 38

Feb 27, 2017: Respiri: Interim Financial Report for the Half Year Ended December 2016 39

Section 6-Appendix 40

Methodology 40

Ratio Definitions 40

About GlobalData 44

Contact Us 44

Disclaimer 44

List of Figures

Respiri Ltd, Performance Chart (2014-2018) 22

Respiri Ltd, Ratio Charts 24

Respiri Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Respiri Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 26

List of Tables

Respiri Ltd, Key Facts 5

Respiri Ltd, Key Employees 6

Respiri Ltd, Key Employee Biographies 7

Respiri Ltd, Major Products and Services 8

Respiri Ltd, History 9

Respiri Ltd, Subsidiaries 11

Respiri Ltd, Key Competitors 18

Respiri Ltd, Ratios based on current share price 19

Respiri Ltd, Annual Ratios 20

Respiri Ltd, Annual Ratios (Cont...1) 21

Respiri Ltd, Interim Ratios 23

Respiri Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 25

Respiri Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 26

Respiri Ltd, Recent Deals Summary 27

Currency Codes 40

Capital Market Ratios 40

Equity Ratios 41

Profitability Ratios 41

Cost Ratios 42

Liquidity Ratios 42

Leverage Ratios 43

Efficiency Ratios 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Vision Eye Institute Ltd

Cortical Pty Ltd

iNova Pharmaceuticals (Australia) Pty Ltd

Compumedics Ltd

Parker Healthcare Pty Ltd

Alphapharm Pty Ltd

Respiri Ltd, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8599
Site License
USD 250 INR 17198
Corporate User License
USD 375 INR 25796

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com